Evolution Infographics

Biotechnology & Biopharmaceutical industry data visualisation and analysis by Evolution.

March 2, 2017

The Antibody Quality Conundrum: Abcam Ahead of the Curve with Knockout Validation

[vc_row][vc_column][vc_column_text] In September 2016 the International Working Group for Antibody Validation (IWGAV) finally announced their five conceptual pillars, outlining recommendations to mitigate the antibody specificity and […]
February 20, 2017

Pharmaron Continue Their Global Expansion with Grand Opening of Hoddesdon Facility

[vc_row][vc_column][vc_column_text] Fully integrated contract research and manufacturing organisation Pharmaron have formally opened their Hoddesdon facility, making it the first Sino-US CRO to operate in each major […]
January 27, 2017

Lonza Accelerates its “Healthcare Continuum” Strategy with $5.5B Acquisition of Capsugel

[vc_row][vc_column][vc_column_text] At the end of 2016 Lonza entered into an agreement to acquire Capsugel for $5.5B in cash, including refinancing of $2B of existing Capsugel debt. […]
January 12, 2017

Drug Development IPO Analysis: Over $4.2B Raised Globally in Q4 2016 Despite Continued NASDAQ Decline

[vc_row][vc_column][vc_column_text] Whilst the depression in the value and frequency of Drug Development IPOs on the NASDAQ market continued throughout the fourth quarter of 2016, a combined […]
November 29, 2016

Promising Autologous CAR-T Cell Therapies Stumble: is this the End, or Just the Beginning?

[vc_row][vc_column][vc_column_text]The field of CAR-T immunotherapy presents a tantalising idea: reengineering a patient’s immune cells to attack cancer. CAR-T immunotherapy has the potential to revolutionise the way […]
November 9, 2016

Blood of Their Blood: Young Blood Transfusions & The Business of Ageing

[vc_row][vc_column][vc_column_text]The idea of transfusing blood from younger individuals to older individuals has returned to the spotlight following the commencement of clinical trials by US companies Alkahest […]
September 14, 2016

Cancer Immunotherapy: A Developmental Timeline & Examination of the Prior Art Paradox

[vc_row][vc_column][vc_column_text]The American Society of Clinical Oncology (ASCO) recently named cancer immunotherapy as the 2016 Advance of the Year, with President Dr. Julie Vose noting that “no […]